Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6237622B2 - - Google Patents
[go: Go Back, main page]

JPS6237622B2 - - Google Patents

Info

Publication number
JPS6237622B2
JPS6237622B2 JP54075490A JP7549079A JPS6237622B2 JP S6237622 B2 JPS6237622 B2 JP S6237622B2 JP 54075490 A JP54075490 A JP 54075490A JP 7549079 A JP7549079 A JP 7549079A JP S6237622 B2 JPS6237622 B2 JP S6237622B2
Authority
JP
Japan
Prior art keywords
acid
amidinophenyl
methyl
amidinophenol
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54075490A
Other languages
Japanese (ja)
Other versions
JPS55167275A (en
Inventor
Setsuo Fujii
Eizo Hatsutori
Mitsuteru Hirata
Hisashi Kunieda
Kazuhiro Onoki
Koichiro Watanabe
Masahiko Nagakura
Nobuo Yokoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Priority to JP7549079A priority Critical patent/JPS55167275A/en
Publication of JPS55167275A publication Critical patent/JPS55167275A/en
Publication of JPS6237622B2 publication Critical patent/JPS6237622B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Indole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は新規なアミジノフエニルエステル誘導
体、更に詳細には次の一般式() (式中、Rは2−フリル、2−もしくは3−チ
エニル、2−(2−チエニル)ビニル、3−ピリ
ジル、6−メチル−3−ピリジル、5−メチル−
2−ピリジル、3−インドリルメチル、3−(5
−メトキシ−2−メチルインドリル)メチル、1
−(2−メチル−1,2,3,4−テトラヒドロ
イソキノリル)メチル又は2−テニル基を示す) で表わされるアミジノフエニルエステル誘導体及
びその酸付加塩に関する。 本発明者は種々のアミジノフエニルエステル誘
導体を合成し、その薬理作用を検索していたとこ
ろ、上記一般式()で表わされるアミジノフエ
ニルエステル誘導体が種々の蛋白分解酵素、例え
ばキモトリプシン、トリプシン、スロンピン等に
対し阻害作用を有することを見出し、本発明を完
成した。 従つて、本発明は()式で表わされる新規な
アミジノフエニルエステル誘導体を提供するもの
である。 本発明化合物()は、例えば次の反応に従つ
て、複素環族カルボン酸()にアミジノフエノ
ール()を作用させることにより製造される。 (式中、RおよびAは前記と同じものを示す) 一般式()で表わされる複素環族カルボン酸
としては、フランカルボン酸、チオフエンカルボ
ン酸、ピロールカルボン酸、ピリジンカルボン
酸、インドール酢酸、イソキノリン酢酸、チオフ
エン酢酸、チオフエンアクリル酸等が用いられ
る。また、この複素環族カルボン酸()とアミ
ジノフエノール()との反応は通常のエステル
化反応、例えば複素環族カルボン酸またはその反
応性誘導体を直接あるいは縮合剤の存在下アミジ
ノフエノールまたはその反応性誘導体と反応させ
ることにより実施される。 このようにして得られた化合物()は、更
に、常法に従つて、例えば塩酸、硫酸、リン酸お
よび臭化水素酸等の無機酸塩;あるいは酢酸、プ
ロピオン酸、マレイン酸、フマル酸、酒石酸、ク
エン酸、メタンスルホン酸、ベンゼンスルホン酸
およびトルエンスルホン酸等の有機酸塩に導くこ
とができる。 斯くして得られた本発明化合物()の酵素阻
害作用を試験した結果は次の通りである。 (1) キモトリプシン阻害作用 村松らの方法〔ザ・ジヤーナル・オブ・ビオ
ケミストリー62,408(1967)参照〕により、
被検化合物のジメチルスルホキシド溶液0.1
ml、水0.1ml及びキモトリプシン10μg/mlの
緩衝液溶液(0.1Mトリス−塩酸緩衝液;PH
8.0)0.1mlを混合した溶液を10分間インキユベ
ートし、これにアセチル−L−チロシンエチル
エステル25mMの緩衝液溶液0.2mlを混合し、
37℃で30分間反応させ、残存する基質の量をヘ
ステリン法により発色させ、530nmの吸光度を
測定し求めた。なお比較化合物としてキモトリ
プシンの阻害剤として知られるトシルフエニル
アラニンクロロメチルケトン(TPCK)を用い
た。 結果は第1表の通りである。 (2) トリプシン阻害作用 村松らの方法〔ザ・ジヤーナル・オブ・ビオ
ケミストリー58,214(1967)参照〕により、
被検化合物のジメチルスルホキシド溶液0.1
ml、緩衝液(0.1Mトリス−塩酸緩衝液:PH8.0
に塩化カルシウム10mMを溶解した溶液)0.1
mlおよびトリプシン2.5μg/mlの緩衝液溶液
0.1mlを混合した溶液を10分間インキユベート
し、これにトシルアルギニンメチルエステル
25mMの緩衝液溶液0.2mlを混合し、37℃で30
分間反応させ、残存する基質の量をヘステリン
法により発色させ、530nmの吸光度を測定し求
めた。 結果は第1表の通りである。 (3) スロンビン阻害作用測定法 田村らの方法〔バイオキミカ・エト・バイオ
フイズイカ・マクタ484,417(1977)参照〕に
より被検化合物のジメチルスルホキシド溶液
0.1ml、緩衝液(0.1Mリン酸ナトリウム緩衝
液:PH7.4)0.1mlおよびスロンビン37.5unit/
mlの緩衝液溶液0.1mlを混合した溶液を10分間
インキユベートし、これにトシルアルギニンメ
チルエステル25mMの緩衝液溶液0.2mlを混合
し、37℃で30分間反応させ、残存する基質の量
をヘステリン法により発色させ、530nmの吸光
度を測定し求めた。 結果は第1表の通りである。
The present invention provides novel amidinophenyl ester derivatives, more specifically, the following general formula () (wherein R is 2-furyl, 2- or 3-thienyl, 2-(2-thienyl)vinyl, 3-pyridyl, 6-methyl-3-pyridyl, 5-methyl-
2-pyridyl, 3-indolylmethyl, 3-(5
-methoxy-2-methylindolyl)methyl, 1
The invention relates to an amidinophenyl ester derivative represented by -(2-methyl-1,2,3,4-tetrahydroisoquinolyl)methyl or 2-tenyl group) and its acid addition salt. The present inventor synthesized various amidinophenyl ester derivatives and searched for their pharmacological actions, and found that the amidinophenyl ester derivatives represented by the above general formula ( The present invention was completed based on the discovery that it has an inhibitory effect on thrombin and the like. Therefore, the present invention provides a novel amidinophenyl ester derivative represented by the formula (). The compound () of the present invention is produced by reacting a heterocyclic carboxylic acid () with an amidinophenol (), for example, according to the following reaction. (In the formula, R and A are the same as above.) Examples of the heterocyclic carboxylic acid represented by the general formula () include furancarboxylic acid, thiophenecarboxylic acid, pyrrolecarboxylic acid, pyridinecarboxylic acid, indoleacetic acid, Isoquinoline acetic acid, thiophene acetic acid, thiophene acrylic acid, etc. are used. In addition, the reaction between this heterocyclic carboxylic acid (2) and amidinophenol (2) can be carried out using a normal esterification reaction, for example, by directly reacting the heterocyclic carboxylic acid or its reactive derivative or in the presence of a condensing agent with amidinophenol or its reactive derivative. It is carried out by reacting with a derivative. The compound () obtained in this way can be further treated with inorganic acid salts such as hydrochloric acid, sulfuric acid, phosphoric acid and hydrobromic acid; or acetic acid, propionic acid, maleic acid, fumaric acid, It can lead to organic acid salts such as tartaric acid, citric acid, methanesulfonic acid, benzenesulfonic acid and toluenesulfonic acid. The results of testing the enzyme inhibitory effect of the thus obtained compound of the present invention () are as follows. (1) Chymotrypsin inhibitory effect According to the method of Muramatsu et al. [see The Journal of Biochemistry 62 , 408 (1967)],
Dimethyl sulfoxide solution of test compound 0.1
ml, water 0.1 ml and chymotrypsin 10 μg/ml buffer solution (0.1 M Tris-HCl buffer; PH
8.0) Incubate the mixed solution of 0.1 ml for 10 minutes, mix it with 0.2 ml of acetyl-L-tyrosine ethyl ester 25mM buffer solution,
The reaction was carried out at 37°C for 30 minutes, and the amount of remaining substrate was determined by developing color using the hesterin method and measuring the absorbance at 530 nm. Note that tosylphenylalanine chloromethyl ketone (TPCK), which is known as a chymotrypsin inhibitor, was used as a comparison compound. The results are shown in Table 1. (2) Trypsin inhibitory effect According to the method of Muramatsu et al. [see The Journal of Biochemistry 58 , 214 (1967)],
Dimethyl sulfoxide solution of test compound 0.1
ml, buffer solution (0.1M Tris-HCl buffer: PH8.0
solution of 10mM calcium chloride in) 0.1
ml and trypsin 2.5 μg/ml buffer solution
Incubate the mixed solution of 0.1 ml for 10 minutes, and add tosyl arginine methyl ester to this solution.
Mix 0.2 ml of 25 mM buffer solution and incubate at 37 °C for 30
After reacting for a minute, the amount of remaining substrate was determined by color development using the hesterin method and absorbance at 530 nm was measured. The results are shown in Table 1. ( 3 ) Method for measuring thrombin inhibitory effect Test compound in dimethyl sulfoxide solution using the method of Tamura et al.
0.1ml, buffer (0.1M sodium phosphate buffer: PH7.4) 0.1ml and thrombin 37.5unit/
ml of buffer solution was incubated for 10 minutes, mixed with 0.2 ml of tosylarginine methyl ester 25mM buffer solution, reacted for 30 minutes at 37°C, and the amount of remaining substrate was determined using the hesterin method. The color was developed and the absorbance at 530 nm was measured. The results are shown in Table 1.

【表】【table】

【表】 第1表に示す結果から明らかな如く、本発明化
合物()は優れた蛋白分解酵素阻害作用を有
し、キモトリプシン、トリプシンおよびスロンビ
ン阻害剤として有用なものである。 以下更に実施例を挙げて説明する。 実施例 1 4′−アミジノフエニル フラン−2−カルボキ
シレート: p−アミジノフエノール・一塩酸塩1.73gのピ
リジン20ml溶液にフラン−2−カルボニルクロリ
ド2.61gを氷冷下滴下し、室温下で4時間反応さ
せた。反応終了後、生じた不溶物を去し、母液
にエーテルを加えると結晶化した。水およびメタ
ノール−エーテルより各一回再結晶すれば無色結
晶として4′−アミジノフエニルフラン−2−カル
ボキシレート・一塩酸塩1.45g(収率54.3%)を
得た。 融点:216〜9℃ 元素分析値:C12H10N2O3・HClとして C H N Cl 計算値(%) 54.05 4.16 10.50 13.29 実験値(%) 54.06 4.23 10.63 13.23 実施例 2 4′−アミジノフエニル チオフエン−2−カル
ボキシレート: p−アミジノフエノール・一塩酸塩1.73gとチ
オフエン−2−カルボニルクロリド2.93gを使用
し、実施例1と同一に処理すれば、無色結晶とし
て4′−アミジノフエニル チオフエン−2−カル
ボキシレート・一塩酸塩1.50g(収率53%)が得
られた。 融点:215〜8℃ 元素分析値:C12H10N2O2S・HClとして C H N Cl 計算値(%) 50.98 3.92 9.91 12.54 実験値(%) 51.07 3.92 10.12 12.40 実施例 3 4′−アミジノフエニル チオフエン−3−カル
ボキシレート: p−アミジノフエノール0.86gとチオフエン−
3−カルボニルクロリド1.47gを使用し、実施例
1と同一に処理すれば、無色結晶として4′−アミ
ジノフエニル チオフエン−3−カルボキシレー
ト・一塩酸塩0.47g(収率33.3%)が得られた。 融点:227.5〜9.5℃ 元素分析値:C12H10N2O2S・HClとして C H N Cl 計算値(%) 50.98 3.92 9.91 12.54 実験値(%) 51.03 4.14 9.76 12.62 実施例 4 4′−アミジノフエニル チオフエン−2−アク
リレート: p−アミジノフエノール1.73gとチオフエン−
2−アクロイルクロリド3.45gを使用し、実施例
1と同一に処理すれば無色結晶として4′−アミジ
ノフエニル チオフエン−2−アクリレート1.30
g(収率42.0%)を得た。 融点:221.5〜2.5℃ 元素分析値:C14H12N2O2S・HClとして C H N Cl 計算値(%) 54.46 4.24 9.07 11.48 実験値(%) 54.53 4.27 9.24 11.32 実施例 5 4′−アミジノフエニルピリジン−3−カルボキ
シレート: p−アミジノフエノール・一塩酸塩3.6gのピ
リジン25ml溶液にニコチン酸クロリド・一塩酸塩
7.5gを氷冷下すばやく加え室温で一夜撹拌し
た。析出沈澱を取後クロロホルムで洗滌し、水
より再結晶すれば無色結晶として4′−アミジノフ
エニルピリジン−3−カルボキシレート・二塩酸
塩2.6g(収率39.6%)が得られた。 融点:240〜4℃(分解) 元素分析値:C13H11N3O2・2HClとして C H N Cl 計算値(%) 49.70 4.17 13.37 22.57 実験値(%) 49.78 4.18 13.19 22.71 実施例 6 4′−アミジノフエニル 6−メチルピリジン−
3−カルボキシレート: 6−メチルピリジン−3−カルボン酸1.4gお
よび4−アミジノフエノール・一塩酸塩0.9gの
ピリジン12ml溶液に、氷冷下、ジシクロヘキシル
カルボジイミド2.1gを撹拌下に加えた。室温に
て一夜撹拌し、析出物を取、メタノール抽出後
濃縮し、水より再結晶すれば4′−アミジノフエニ
ル 6−メチルピリジン−3−カルボキシレー
ト・一塩酸塩の無色結晶0.7g(収率45.8%)が
得られた。 融点:218〜20℃ 元素分析値:C14H13N3O2・HClとして C H N Cl 計算値(%) 57.64 4.84 14.40 12.15 実験値(%) 57.59 4.82 14.29 12.31 実施例 7 4′−アミジノフエニル 5−メチルピリジン−
2−カルボキシレート: 5−メチルピリジン−2−カルボン酸1.4gお
よび4−アミジノフエノール・一塩酸塩0.9gの
ピリジン溶液に氷冷下、ジシクロヘキシルカルボ
ジイミド2.1gを撹拌下に加えた。室温にて一夜
撹拌し、析出物を取、メタノール抽出後、氷冷
下に塩酸−メタノールを加えて濃縮し、エタノー
ル−酢酸エチルから再結晶すれば無色結晶として
4′−アミジノフエニル 5−メチルピリジン−2
−カルボキシレート・二塩酸塩1.0g(収率46.4
%)が得られた。 融点:198〜9℃(分解) 元素分析値:C14H13N3O2・2HCl C H N Cl 計算値(%) 51.24 4.61 12.80 21.60 実験値(%) 51.13 4.62 12.69 21.81 実施例 8 4′−アミジノフエニル インドール−3−アセ
テート: p−アミジノフエノール・一メタンスルホン酸
塩2.32g、β−インドール酢酸3.84g及び4−ピ
ロリジノピリジン150mgのジメチルホルムアミド
20ml溶液に、氷冷下、ジシクロヘキシルカルボジ
イミド4.54gを撹拌下に加えた。一時間後、室温
に戻し一夜撹拌したのち、不溶物を去し、母液
にエーテルを加えると粉末が得られた。メタノー
ル−エーテルより再結晶すると、融点223〜226℃
の結晶として、4′−アミジノフエニル インドー
ル−3−アセテート・一メタンスルホン酸塩1.20
g(収率30.8%)が得られた。 元素分析値:C17H15N3O2・CH3SO3Hとして C H N 計算値(%) 55.52 4.92 10.79 実験値(%) 55.51 4.98 10.80 実施例 9 4′−アミジノフエニル 5−メトキシ−2−メ
チルインドール−3−アセテート: 5−メトキシ−2−メチルインドール−3−酢
酸3.35g及びp−アミジノフエノール・塩酸塩
1.72gのピリジン20ml溶液にジシクロヘキシルカ
ルボジイミド3.72gを加え、室温にて一夜撹拌し
た。不溶物を去し、母液にエーテルを加えると
油状物が析出した。これをシリカゲルカラムクロ
マトグラフイー(溶出溶媒:クロロホルム−メタ
ノール−酢酸;85:20:5)にて精製すれば結晶
が得られた。これをメタノール−エーテルにて再
結晶すると、融点188〜192.5℃の淡黄色結晶とし
て、4′−アミジノフエニル 5−メトキシ−2−
メチルインドール−3−アセテート・塩酸塩1.35
g(収率36.2%)が得られた。 元素分析値:C19H19N3O3・HClとして C H N 計算値(%) 61.04 5.39 11.24 実験値(%) 61.00 5.36 11.19 実施例 10 4′−アミジノフエニル 2−メチル−1,2,
3,4−テトラヒドロイソキノリン−1−アセ
テート: p−アミジノフエノール・一メタンスルホン酸
塩2.32g及び2−メチル−1,2,3,4−テト
ラヒドロイソキノリン−1−酢酸・塩酸塩2.46g
のピリジン30ml溶液にジシクロヘキシルカルボジ
イミド2.48gを加え、室温で一夜撹拌した。不溶
物を去した後、酢酸エチルを加えると粉末が得
られた。これに水を加え、不溶物を去した後、
減圧濃縮し、五酸化リン上にて乾燥し、酢酸エチ
ルを加えると融点137〜140℃の粉末として、4′−
アミジノフエニル 2−メチル−1,2,3,4
−テトラヒドロイソキノリン−1−アセテート・
一メタンスルホン酸・一塩酸塩1.60g(収率35.1
%)が得られた。 元素分析値:C19H21N3O2・CH3SO3H・HClと
して C H N 計算値(%) 52.68 5.75 9.22 実験値(%) 52.39 5.49 9.15
[Table] As is clear from the results shown in Table 1, the compound () of the present invention has an excellent protease inhibitory effect and is useful as a chymotrypsin, trypsin and thrombin inhibitor. Examples will be further described below. Example 1 4'-amidinophenyl furan-2-carboxylate: 2.61 g of furan-2-carbonyl chloride was added dropwise to a 20 ml solution of pyridine containing 1.73 g of p-amidinophenol monohydrochloride under ice cooling, and the mixture was reacted at room temperature for 4 hours. I let it happen. After the reaction was completed, the resulting insoluble matter was removed, and ether was added to the mother liquor, resulting in crystallization. Recrystallization once each from water and methanol-ether gave 1.45 g (yield 54.3%) of 4'-amidinophenylfuran-2-carboxylate monohydrochloride as colorless crystals. Melting point: 216-9℃ Elemental analysis value: C H N Cl Calculated value (%) 54.05 4.16 10.50 13.29 Experimental value (%) 54.06 4.23 10.63 13.23 Example 2 4' - amidinophenyl Thiophene-2-carboxylate: If 1.73 g of p-amidinophenol monohydrochloride and 2.93 g of thiophene-2-carbonyl chloride are used and treated in the same manner as in Example 1, 4'-amidinophenol thiophene-2 is obtained as colorless crystals. -Carboxylate monohydrochloride 1.50 g (yield 53%) was obtained. Melting point: 215-8℃ Elemental analysis value: C 12 H 10 N 2 O 2 As S・HCl C H N Cl Calculated value (%) 50.98 3.92 9.91 12.54 Experimental value (%) 51.07 3.92 10.12 12.40 Example 3 4'- Amidinophenyl thiophene-3-carboxylate: 0.86 g of p-amidinophenol and thiophene-3-carboxylate
When 1.47 g of 3-carbonyl chloride was used and treated in the same manner as in Example 1, 0.47 g (yield: 33.3%) of 4'-amidinophenyl thiophene-3-carboxylate monohydrochloride was obtained as colorless crystals. Melting point: 227.5-9.5℃ Elemental analysis value: C 12 H 10 N 2 O 2 S・HCl Calculated value (%) 50.98 3.92 9.91 12.54 Experimental value (%) 51.03 4.14 9.76 12.62 Example 4 4'- Amidinophenyl thiophene-2-acrylate: 1.73 g of p-amidinophenol and thiophene-2-acrylate
If 3.45 g of 2-acroyl chloride is used and treated in the same manner as in Example 1, 1.30 g of 4'-amidinophenyl thiophene-2-acrylate will be obtained as colorless crystals.
g (yield 42.0%). Melting point: 221.5-2.5℃ Elemental analysis value: C 14 H 12 N 2 O 2 S・HCl Calculated value (%) 54.46 4.24 9.07 11.48 Experimental value (%) 54.53 4.27 9.24 11.32 Example 5 4'- Amidinophenylpyridine-3-carboxylate: Nicotinic acid chloride monohydrochloride in 25ml pyridine solution of 3.6g p-amidinophenol monohydrochloride.
7.5 g was quickly added under ice-cooling, and the mixture was stirred at room temperature overnight. The precipitate was collected, washed with chloroform, and recrystallized from water to obtain 2.6 g (yield: 39.6%) of 4'-amidinophenylpyridine-3-carboxylate dihydrochloride as colorless crystals. Melting point: 240-4℃ (decomposition) Elemental analysis value: C 13 H 11 N 3 O 2.2HCl Calculated value (%) 49.70 4.17 13.37 22.57 Experimental value (%) 49.78 4.18 13.19 22.71 Example 6 4 '-amidinophenyl 6-methylpyridine-
3-Carboxylate: To a solution of 1.4 g of 6-methylpyridine-3-carboxylic acid and 0.9 g of 4-amidinophenol monohydrochloride in 12 ml of pyridine, 2.1 g of dicyclohexylcarbodiimide was added with stirring under ice cooling. Stir overnight at room temperature, collect the precipitate, extract with methanol, concentrate, and recrystallize from water to obtain 0.7 g of colorless crystals of 4'-amidinophenyl 6-methylpyridine-3-carboxylate monohydrochloride (yield 45.8). %)was gotten. Melting point: 218-20℃ Elemental analysis value: C 14 H 13 N 3 O 2・HCl Calculated value (%) 57.64 4.84 14.40 12.15 Experimental value (%) 57.59 4.82 14.29 12.31 Example 7 4′-amidinophenyl 5-methylpyridine-
2-Carboxylate: To a pyridine solution of 1.4 g of 5-methylpyridine-2-carboxylic acid and 0.9 g of 4-amidinophenol monohydrochloride was added 2.1 g of dicyclohexylcarbodiimide under ice cooling and stirring. Stir overnight at room temperature, collect the precipitate, extract with methanol, add hydrochloric acid-methanol under ice cooling, concentrate, and recrystallize from ethanol-ethyl acetate to obtain colorless crystals.
4'-amidinophenyl 5-methylpyridine-2
-Carboxylate dihydrochloride 1.0g (yield 46.4
%)was gotten. Melting point: 198-9℃ (decomposition) Elemental analysis value: C 14 H 13 N 3 O 2・2HCl C H N Cl Calculated value (%) 51.24 4.61 12.80 21.60 Experimental value (%) 51.13 4.62 12.69 21.81 Example 8 4' -Amidinophenyl indole-3-acetate: 2.32 g of p-amidinophenol monomethanesulfonate, 3.84 g of β-indoleacetic acid and 150 mg of 4-pyrrolidinopyridine in dimethylformamide.
4.54 g of dicyclohexylcarbodiimide was added to the 20 ml solution under ice cooling and stirring. After one hour, the mixture was returned to room temperature and stirred overnight. Insoluble matters were removed and ether was added to the mother liquor to obtain a powder. When recrystallized from methanol-ether, the melting point is 223-226℃.
As crystals of 4'-amidinophenyl indole-3-acetate monomethanesulfonate 1.20
g (yield 30.8%) was obtained. Elemental analysis value: C H N Calculated value (%) 55.52 4.92 10.79 Experimental value (%) 55.51 4.98 10.80 Example 9 4' - amidinophenyl 5 - methoxy-2 -Methylindole-3-acetate: 3.35 g of 5-methoxy-2-methylindole-3-acetic acid and p-amidinophenol hydrochloride
3.72 g of dicyclohexylcarbodiimide was added to a 20 ml solution of 1.72 g of pyridine, and the mixture was stirred at room temperature overnight. Insoluble materials were removed and ether was added to the mother liquor to precipitate an oil. When this was purified by silica gel column chromatography (elution solvent: chloroform-methanol-acetic acid; 85:20:5), crystals were obtained. When this was recrystallized from methanol-ether, 4'-amidinophenyl 5-methoxy-2-
Methylindole-3-acetate hydrochloride 1.35
g (yield 36.2%) was obtained. Elemental analysis value: C H N Calculated value (%) 61.04 5.39 11.24 Experimental value (%) 61.00 5.36 11.19 Example 10 4'-amidinophenyl 2 - methyl-1,2,
3,4-Tetrahydroisoquinoline-1-acetate: 2.32 g of p-amidinophenol monomethanesulfonate and 2.46 g of 2-methyl-1,2,3,4-tetrahydroisoquinoline-1-acetic acid hydrochloride.
2.48 g of dicyclohexylcarbodiimide was added to a 30 ml solution of pyridine, and the mixture was stirred at room temperature overnight. After removing insoluble materials, ethyl acetate was added to obtain a powder. After adding water to this and removing insoluble matter,
Concentrate under reduced pressure, dry over phosphorus pentoxide, and add ethyl acetate to obtain 4′-
Amidinophenyl 2-methyl-1,2,3,4
-Tetrahydroisoquinoline-1-acetate・
Monomethanesulfonic acid monohydrochloride 1.60g (yield 35.1
%)was gotten. Elemental analysis value: C 19 H 21 N 3 O 2・CH 3 SO 3 H・HCl C H N Calculated value (%) 52.68 5.75 9.22 Experimental value (%) 52.39 5.49 9.15

Claims (1)

【特許請求の範囲】 1 一般式 (式中、Rは2−フリル、2−もしくは3−チ
エニル、2−(2−チエニル)ビニル、3−ピリ
ジル、6−メチル−3−ピリジル、5−メチル−
2−ピリジル、3−インドリルメチル、3−(5
−メトキシ−2−メチルインドリル)メチル、1
−(2−メチル−1,2,3,4−テトラヒドロ
イソキノリル)メチル又は2−テニル基を示す) で表わされるアミジノフエニルエステル誘導体及
びその酸付加塩。
[Claims] 1. General formula (wherein R is 2-furyl, 2- or 3-thienyl, 2-(2-thienyl)vinyl, 3-pyridyl, 6-methyl-3-pyridyl, 5-methyl-
2-pyridyl, 3-indolylmethyl, 3-(5
-methoxy-2-methylindolyl)methyl, 1
An amidinophenyl ester derivative represented by -(2-methyl-1,2,3,4-tetrahydroisoquinolyl)methyl or 2-tenyl group) and its acid addition salt.
JP7549079A 1979-06-15 1979-06-15 Preparation of amidinophenyl ester derivative Granted JPS55167275A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7549079A JPS55167275A (en) 1979-06-15 1979-06-15 Preparation of amidinophenyl ester derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7549079A JPS55167275A (en) 1979-06-15 1979-06-15 Preparation of amidinophenyl ester derivative

Publications (2)

Publication Number Publication Date
JPS55167275A JPS55167275A (en) 1980-12-26
JPS6237622B2 true JPS6237622B2 (en) 1987-08-13

Family

ID=13577769

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7549079A Granted JPS55167275A (en) 1979-06-15 1979-06-15 Preparation of amidinophenyl ester derivative

Country Status (1)

Country Link
JP (1) JPS55167275A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59139357A (en) * 1983-01-28 1984-08-10 Torii Yakuhin Kk Amidine derivative
ES2618024T3 (en) 2011-06-07 2017-06-20 Ea Pharma Co., Ltd. Heterocyclic carboxylic acid ester derivative

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions

Also Published As

Publication number Publication date
JPS55167275A (en) 1980-12-26

Similar Documents

Publication Publication Date Title
US5296495A (en) Thiazolylbenzofuran derivatives and pharmaceutical composition comprising the same
CA1103246A (en) Thiazine derivatives
US5985894A (en) N-substituted quinolines
PL172035B1 (en) Endothelin antagonist sulfonamide derivatives PL PL PL PL PL
JPH07267964A (en) Novel N-heterocyclic thienothiazine carboxamide, its production method and its use
US5001137A (en) Pyridine compounds and pharmaceutical use thereof
KR20060059910A (en) Biaryloxymethyl arene-carboxylic acid
JPH03130289A (en) Nitrogen containing condensed-ring thiophene and furan derivative
US4299831A (en) 2-Trifluoromethyl-3-quinoline carboxamides, analgesic and anti-inflammatory compositions and methods employing them
KR20010022362A (en) 0-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents
CA1247099A (en) 2-oxoindole 3-carboxamide derivative antiinflammatory agents
US4224445A (en) Thienothiazine derivatives
JPH072770A (en) New substituted indole, its production and pharmaceutical composition containing said indole
FI59253B (en) PROCEDURE FOR THERAPEUTIC PREPARATION OF THERAPEUTIC 4-HYDROXY-2H-THIENO (2,3-E) OCH (3,4-E) -1,2-THIAZINE-3-CARBOXAMIDE-1,1-DIOXIDE DERIVATIVES
US4988708A (en) Analgesic and anti-inflammatory 4-OH quinoline carboxylic acid derivatives
US5116854A (en) Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles
GB2058773A (en) Cyclohexane carboxylic acid derivatives
EP0210078A2 (en) Cephalosporin derivatives
Baggaley et al. Inhibitors of blood platelet aggregation. Effects of some 1, 2-benzisothiazol-3-ones on platelet responsiveness to adenosine diphosphate and collagen
JPS6237622B2 (en)
HU182257B (en) Process for producing benzothiazole derivatives and pharmaceutical compositions containing them as active agents
JPH0378854B2 (en)
EP0117345B1 (en) Aminopyrimidinones as histamine h2-antagonists
JPH03106875A (en) 1-(3-pyridylmethyl)phthalazine derivative
EP0065825B1 (en) Pyridine derivatives as histamine h2 antagonists